CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
High ImpactOriginal article

Telix to buy Germany’s ITM Isotope for $1.65B to expand radiopharma footprint

Positive
AI Analysis

Summary

Telix Pharmaceuticals is acquiring Germany-based ITM Isotope for $1.65 billion to expand its radiopharmaceutical portfolio and capabilities.

Importance:8/10
Sentiment:
0.60
M&AacquisitionradiopharmaceuticalsGermanyexpansion
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 21, 2026 4:52 AM

Read Original